相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Natural killer cells: The journey from puzzles in biology to treatment of cancer
Lakshmi Narendra Bodduluru et al.
CANCER LETTERS (2015)
Natural killer cells for cancer immunotherapy: pluripotent stem cells-derived NK cells as an immunotherapeutic perspective
Cristina Eguizabal et al.
FRONTIERS IN IMMUNOLOGY (2015)
KIR haplotype B donors but not KIR-ligand mismatch result in a reduced incidence of relapse after haploidentical transplantation using reduced intensity conditioning and CD3/CD19-depleted grafts
Sebastian U. Michaelis et al.
ANNALS OF HEMATOLOGY (2014)
KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL
Lena Oevermann et al.
BLOOD (2014)
Past, present and future targets for immunotherapy in ovarian cancer
Carlton L. Schwab et al.
IMMUNOTHERAPY (2014)
Donor Killer Cell Ig-like Receptor B Haplotypes, Recipient HLA-C1, and HLA-C Mismatch Enhance the Clinical Benefit of Unrelated Transplantation for Acute Myelogenous Leukemia
Sarah Cooley et al.
JOURNAL OF IMMUNOLOGY (2014)
An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models
Suzie J. Scales et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies
Gregory L. Beatty et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Donor haplotype B of NK KIR receptor reduces the relapse risk in HLA-icentical sibling hematopoetic stem cell transplantation of AML patients
Ulla Impola et al.
FRONTIERS IN IMMUNOLOGY (2014)
Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model
Melissa A. Geller et al.
CYTOTHERAPY (2013)
Natural killer cells: a review of manufacturing and clinical utility
Scott A. Koepsell et al.
TRANSFUSION (2013)
Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy
David A. Knorr et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
Cecele J. Denman et al.
PLOS ONE (2012)
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
Melissa A. Geller et al.
CYTOTHERAPY (2011)
Human Pluripotent Stem Cells Produce Natural Killer Cells That Mediate Anti-HIV-1 Activity by Utilizing Diverse Cellular Mechanisms
Zhenya Ni et al.
JOURNAL OF VIROLOGY (2011)
Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
Sarah Cooley et al.
BLOOD (2010)
Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity
Petter S. Woll et al.
BLOOD (2009)
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
Carmine Carpenito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies
Elizabeth S. Ng et al.
NATURE PROTOCOLS (2008)
Prospects for the use of NK cells in immunotherapy of human cancer
Hans-Gustaf Ljunggren et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
Relapsed ovarian cancer: Challenges and management strategies for a chronic disease
DK Armstrong
ONCOLOGIST (2002)
Hematopoietic colony-forming cells derived from human embryonic stem cells
DS Kaufman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
